EVs containing high mobility group box 1 (HMGB1) released by HCC cells can enhance the accumulation of TIM-1+ Breg cells via the toll-like receptor (TLR) 2/4 and mitogen-activated protein kinase (MAPK) pathway [69]. The gene discussed is HMGB1; the disease is hepatocellular carcinoma.